Press releases
- PacBio and International Research Consortium CoLoRS Announce Release of First-Ever HiFi Long-Read Variant Database
- Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases
- PacBio Announces First Quarter 2024 Financial Results
- PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance
Key statistics
As of last trade Pacific Biosciences of California Inc (P09:BER) traded at 1.19, 8.07% above its 52-week low of 1.10, set on Jul 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.19 |
---|---|
High | 1.19 |
Low | 1.19 |
Bid | 1.19 |
Offer | 1.24 |
Previous close | 1.15 |
Average volume | 13.50k |
---|---|
Shares outstanding | 272.36m |
Free float | 267.17m |
P/E (TTM) | -- |
Market cap | 354.06m USD |
EPS (TTM) | -1.14 USD |
Data delayed at least 15 minutes, as of Jul 04 2024 07:03 BST.
More ▼